ArticleAntimicrobial agents and chemotherapy2019

Preclinical evaluation of Amphihevir, a first-in-class clinical Hepatitis C virus NS4B inhibitor.

Xin Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.